Alpha Tau Medical (NASDAQ:DRTS) and Assure (NASDAQ:IONM) Head to Head Review

Alpha Tau Medical (NASDAQ:DRTS) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Alpha Tau Medical and Assure, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0	0	4	0	3.00
Assure	0	0	0	0	N/A

Alpha Tau Medical presently has a consensus price target of $11.75, indicating a potential upside of 443.98%. Given Alpha Tau Medical’s higher possible upside, equities research analysts clearly believe Alpha Tau Medical is more favorable than Assure.

Volatility and Risk

Alpha Tau Medical has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.83, suggesting that its stock price is 83% more volatile than the S&P 500.

Profitability

This table compares Alpha Tau Medical and Assure’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-33.47%	-27.07%
Assure	N/A	N/A	-189.89%

Insider & Institutional Ownership

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 3.8% of Assure shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Alpha Tau Medical and Assure’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$29.16 million	($0.41)	-5.27
Assure	$149,000.00	1.19	-$26.08 million	N/A	N/A

Assure has higher revenue and earnings than Alpha Tau Medical.

Summary

Assure beats Alpha Tau Medical on 5 of the 9 factors compared between the two stocks.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Assure

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.